Category - New Drug Applications
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
FDA Issues Complete Response Letter for Zynquista (sotagliflozin)
Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
U.S. FDA Grants Priority Review for Fedratinib New Drug Application in Myelofibrosis
Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
TB Medicine Pretomanid Enters Regulatory Review Process in the United States
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne